Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim Management Statement

12th May 2014 14:20

RNS Number : 8760G
Alternative Asset Opps PCC Ltd
12 May 2014
 



 

 

12 May 2014

Alternative Asset Opportunities PCC Limited

(the "Company")

Interim Management Statement

 

This interim management statement relates to the period from 1 January 2014 to the date of publication of this statement and has been prepared solely to provide additional information in order to meet the relevant requirement of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

The Company is a closed-ended Guernsey registered protected cell company with one cell known as the US Traded Life Interests Fund (the "Fund").

 

Investment objective

The Company's investment objective in respect of the Fund is to provide investors with an attractive capital return through investment predominantly in a diversified portfolio of US Traded Life Interests ("TLIs").

 

Financial position and performance

Over the period to 31 March 2014, the Company's net asset value per share increased by 0.9% to 46.3 pence. As at 31 March 2014, the shares were trading at an 18.2% discount to that net asset value. As at 9 May 2014 the discount to that net asset value was 17.4%.

 

Three policy maturities on two lives were identified during the period. The gains from the policy maturities were recognised in the 31 January and 28 February 2014 NAVs adding a total of circa 2.7 pence to the NAV per share. There have been, in aggregate, 55 policy maturities across 46 lives since the Fund's inception. Following the policy maturities identified during the period the Company now holds 92 policies covering 81 lives.

 

The Company has received notification of one further policy maturity on one life with a face value of US$2,000,000, which once certified will add approximately 1.1p to the NAV per share.

 

As previously announced, the Company agreed a new revolving loan facility with AIB Group (UK) PLC for up to US$10 million until 31 March 2016. The Company's borrowings as at 31 March 2014 showed a nil balance.

 

Material events and transactions in the period and since 31 March 2014

As previously advised in the Half Yearly Report, the Company put the audit out to tender. Following presentations from a number of international auditing firms, including the Company's current auditors, the Board, following a recommendation from the Audit Committee, decided to retain Deloitte LLP as the Company's auditors.

 

The Board is not aware of any other material events during the period from 1 January 2014 to 31 March 2014, or in the period from 1 April 2014 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

The table below aims to give investors an appreciation of the effects on valuation of different assumptions as to both LE and IRR.

- The first line of NAVs in the table uses the 'Latest LE' assumption, that is to say either an LE based on a recently updated assessment (obtained on or after 1 April 2013) or, for the remaining policies an adjusted LE based on the most recent LE obtained, increased by 12%. The average LE is shown for reference (4.9 years). NAV is then shown at four different discount rates, ranging from 10% to 20%.

 

- The second line shows the effect of an increase of one year in the valuation LEs.

 

- The third line shows the effect of a decrease of one year in the valuation LEs.

 

 

- Finally, the fourth line shows the outcome of assuming LEs are simply based on the current table of life expectancies for the general population, the 2008 Valuation Basic Table, i.e. ignoring medical assessments.

 

Sensitivity Matrix

Net Asset Value in pence per share on various assumptions as at 31 March 2014

 

Mortality Assumptions

 Average LE

(years)

Discount Rates applied to cash flows

10%

Current (12%)

16%

20%

Latest LE

4.9

49.2

46.3

41.5

37.7

+1 year for all LEs

5.9

37.0

34.4

30.2

27.1

-1 year for all LEs

3.9

62.9

59.8

54.7

50.4

Using 2008 VBT

4.8

48.9

45.9

41.0

37.1

 

 

 

Source: SL Investment Management Limited

 

Distribution of Life Expectancy estimates

 

The following table shows the distribution by death benefit of the lives in the portfolio by LE band. Lives are grouped by 6 month LE bands and the table shows the number of lives and the total death benefit in each group. The LEs are the valuation LEs used for the 31 March 2014 valuation.

 

It is important to note that the LE is an average of the estimated length of future lifetime for an individual with a given age and health status. The table is not, therefore, a prediction of when actual maturities will occur and is thus not a cashflow forecast.

 

 

LE Band (Years)

No. of Lives

Total Death Benefit

(US$'000)

% of Death Benefit

Total Valuation

(US$'000)

% of Valuation

0 ≤ LE < 1

0

$ 0

0.0

0

0.0

1 ≤ LE < 2

0

$ 0

0.0

0

0.0

2 ≤ LE < 3

4

$ 9,550

6.5

4,866

9.4

3 ≤ LE < 4

14

$ 20,397

14.0

10,150

19.6

4 ≤ LE < 5

26

$ 48,274

33.1

18,842

36.4

5 ≤ LE < 6

19

$ 35,655

24.4

11,579

22.3

6 ≤ LE < 7

12

$ 21,513

14.7

4,664

9.0

7 ≤ LE < 8

5

$ 9,000

6.2

1,407

2.7

LE ≥ 8

1

$ 1,500

1.0

300

0.6

Total

81

 $ 145,889

100.0

 51,806

 100.0

 

 

The average age of lives assured as at 31 March 2014 was 90.1 years

 

Source: SL Investment Management Limited

 

Top ten holdings

By reference to the most recent portfolio valuation of the Company as at 31 March 2014, the largest ten investments held by the Company, measured by life office exposure, were as follows:

 

 

 

 

Issuer

Number of policies

% Investment Value

% Total Death Benefits

American General Life Insurance Company

10

20.97%

19.23%

Lincoln National Life Insurance Company

14

19.25%

21.61%

Transamerica Life Insurance Company

18

17.03%

15.82%

Massachusetts Mutual Life Insurance Company

4

6.94%

5.23%

MetLife Insurance Company of Connecticut

6

5.44%

4.25%

Security Life of Denver Insurance Company

1

5.09%

4.81%

John Hancock Life Insurance Company (USA)

6

4.54%

5.48%

Aviva Life and Annuity Company

4

3.94%

4.29%

New York Life Insurance and Annuity Corporation

5

3.61%

4.46%

Pacific Life Insurance Company

4

2.58%

5.52%

 

Company Information

 

Launch date 25 March 2004

EPIC TLI

Year end 30 June

Report & Accounts Annual Report posted October, Half-yearly posted February

AGM November

Price Information Financial Times (under INVESTMENT COMPANIES, listed as 'AltAstsOpps.')

 

Investor Information

 

The latest available portfolio information included in the Half Yearly and Annual Reports can be accessed via www.allianzgi.co.uk/TLI (under the Professional Investors section).

 

By order of the Board

Alternative Asset Opportunities PCC Limited

 

Enquiries:

Peter Ingram

Company Secretary Tel: 020 7065 1467

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUBGAUPCGWP

Related Shares:

TLI.L
FTSE 100 Latest
Value8,275.66
Change0.00